文献速递糖尿病肥胖与代谢综合征

血清中链脂肪酸与新发糖尿病风险:4C研究结果

Serum Medium-Chain Fatty Acids and the Risk of Incident Diabetes: Findings From the 4C Study.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

基于中国心脏代谢疾病与癌症队列研究(4C研究)的巢式病例对照研究,纳入新发糖尿病病例1707例及匹配的血糖正常对照1707例,检测基线5种血清中链脂肪酸(MCFAs)。血清辛酸和壬酸与糖尿病风险呈逆向剂量反应关系,OR分别为0.90(95%CI 0.82-0.98)和0.84(95%CI 0.74-0.95);体力活动不足者中逆向关联更明显,高遗传风险者中辛酸的逆向关联增强(与遗传风险评分交互作用P=0.003)。

要点

  • 血清辛酸和壬酸与2型糖尿病风险呈逆向剂量反应关系,OR分别为0.90和0.84。
  • 体力活动不足者中MCFAs与糖尿病的逆向关联更明显(交互作用P=.042、.034、.037)。
  • 高遗传风险者中辛酸的逆向关联增强,辛酸与遗传风险评分交互作用P=.003。

核心结论

  • 血清中链脂肪酸与2型糖尿病风险呈逆向关联,遗传易感性与循环辛酸之间可能存在交互作用调节糖尿病风险。

研究设计与样本

  • 巢式病例对照研究,来自中国心脏代谢疾病与癌症队列研究(4C研究)。
  • 纳入新发糖尿病病例1707例和匹配的血糖正常对照1707例,检测基线5种血清中链脂肪酸。
  • 基于86个2型糖尿病相关遗传变异计算遗传风险评分(GRS)。

主要发现

  • 完全校正的条件logistic回归模型中,血清辛酸与糖尿病风险的OR为0.90(95%CI 0.82-0.98),壬酸为0.84(95%CI 0.74-0.95),呈逆向剂量反应关系。
  • 亚组分析显示,体力活动不足者中MCFAs与糖尿病发病的逆向关联更明显,辛酸、壬酸和癸酸的交互作用P值分别为.042、.034和.037。
  • 高遗传风险者中辛酸与糖尿病风险的逆向关联较高遗传风险者增强,辛酸与GRS对2型糖尿病风险的交互作用P=.003。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Emerging studies have revealed associations between dietary medium-chain fatty acids (MCFAs) and glucose homeostasis. However, the relationship between serum MCFAs and the incidence of diabetes, and potential interactions with genetic predisposition, remains unclear in prospective cohort studies. OBJECTIVE: This work aimed to investigate associations and genetic susceptibility between serum MCFAs and diabetes risk. METHODS: We investigated baseline serum MCFAs (n = 5) in a nested case-control study comprising incident diabetes cases (n = 1707) and matched normoglycemic control individuals (n = 1707) from the China Cardiometabolic Disease and Cancer Cohort Study. Associations between MCFAs and type 2 diabetes mellitus (T2DM) were examined, both overall and stratified by diabetes genetic susceptibility. Genetic risk scores (GRS) were calculated based on 86 T2DM-associated genetic variants. RESULTS: In the fully adjusted conditional logistic regression model, serum octanoic acid and nonanoic acid exhibited inverse dose-response relationships with diabetes risk, showing odds ratios (95% CI) of 0.90 (0.82-0.98) and 0.84 (0.74-0.95), respectively. Subgroup analysis demonstrated that inverse associations between MCFAs and incident diabetes were more pronounced among individuals with physical inactivity (Pinteraction = .042, .034, and .037, for octanoic, nonanoic and decanoic acid, respectively). Moreover, inverse associations of octanoic acid with diabetes risk were notably enhanced among individuals with high genetic risk compared to those with low genetic risk. Statistically significant interactions were observed between octanoic acid and GRS on T2DM risk (Pinteraction = .003). CONCLUSION: These findings provide evidence supporting inverse associations between serum MCFAs and T2DM risk, and reveal potential interplay between genetic susceptibility and circulating octanoic acid in modulating diabetes risk.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Jia X, Lin H, Ding Y, et al. Serum Medium-Chain Fatty Acids and the Risk of Incident Diabetes: Findings From the 4C Study. J Clin Endocrinol Metab. 2025. PMID: 39031583. doi:10.1210/clinem/dgae483

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。